A study of a new pill for swelling due to kidney disease
Treatments studied
Part of Kidney & urinary clinical trials.
This study tests an experimental pill (JMKX003142) to see if it can reduce swelling in people with kidney disease (renal edema) who are already taking water pills. Participating may help reduce fluid buildup and improve comfort, but it's only for patients whose kidney function is not too low.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have swelling (edema) caused by kidney disease.
- Your kidney function must be at a certain level (doctors will check with a blood test).
- You must already be taking a water pill (diuretic), either one type or a combination, and be on a stable dose without changes during the study.
- You must not be on dialysis or expected to need it soon.
- You must be able to sense thirst and drink fluids normally.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called YG1699 to see how it works in people who have both diabetes and kidney disease, including those on dialysis. It may help control blood sugar, but we need to learn more about its effects.
This trial tests a drug (JMKX003142) for people with autosomal dominant polycystic kidney disease that is getting worse quickly. It may help slow down kidney damage.
This study is for healthy volunteers to see how a new experimental drug (JMKX003142) interacts with other drugs in the body. It helps find the right dose for future patients.
This study tests a new tablet (JMKX003948) for people with advanced clear cell kidney cancer. It aims to see if the drug is safe and how well it works.
This trial tests a decision-support tool to help your care team safely adjust water pills (“diuretics”) when you have kidney disease and fluid buildup. It may help reduce swelling by guiding dosing using your home weight and blood pressure.
This study tests a new medicine (JMKX003142) in healthy adults to see if it affects the heart's rhythm. If you qualify, you may help determine whether the drug is safe to use in future patients.
Hear when a new Renal Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.